Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Sarcoidosis Appearing During Anti-Tumor Necrosis Factor-alpha Therapy: A New “Class Effect” Paradoxical Phenomenon
Seminars in Arthritis and Rheumatism, 02/26/09
Massara A et al. - The development of sarcoidosis during treatment with TNF-alpha antagonists represents a rare and paradoxical adverse event. The occurrence of sarcoidosis with all 3 available agents suggests a new “class effect” probably linked to a cytokine disequilibrium in patients receiving anti-TNF-alpha treatment.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sedation during Flexible Bronchoscopy in Patients with Pre-Existing Respiratory Failure: Midazolam versus Midazolam plus Alfentanil
Respiration, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Today in Sarcoidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Choroidal granuloma as an initial manifestation of systemic sarcoidosis
International Ophthalmology, 12/15/09
Heart block: a primary manifestation of sarcoidosis
Europace, 12/14/09
Sarcoidosis Presenting as an Epididymal Mass
Journal of the American Osteopathic Association, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


